Search

everythinglearnresearchcommunity

for

Search:↓

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The pandemic changed the types of skin conditions seen, not the number of visits.

Wound healing can help prevent hair loss from chemotherapy in young rats by increasing interleukin-1β signaling.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Natural adsorbents in cosmetics can significantly reduce skin and hair pollution.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

A potential link exists between unexplained hormone deficiency, hair loss, and testicular tumors, suggesting thorough screening is needed.

Ethical standards are crucial in cosmetic medicine to maintain integrity.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

The patient was diagnosed with oral lichen sclerosus and needs long-term monitoring.

Hair loss can significantly impact a person's mental health, causing issues like anxiety and depression, and stress can trigger hair loss.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Platelet-rich plasma injections significantly improved hair regrowth and thickness in patients with hair loss.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

No treatment fully prevents hair loss from chemotherapy yet.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

UV rays can cause a type of hair loss known as telogen alopecia.

Oral contraceptives may cause hair loss in women.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.